RPG Life Sciences Limited - Asset Resilience Ratio

Latest as of September 2025: 31.67%

RPG Life Sciences Limited (RPGLIFE) has an Asset Resilience Ratio of 31.67% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read RPG Life Sciences Limited debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Rs2.24 Billion
≈ $24.17 Million USD Cash + Short-term Investments

Total Assets

Rs7.06 Billion
≈ $76.32 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how RPG Life Sciences Limited's Asset Resilience Ratio has changed over time. See shareholders equity of RPG Life Sciences Limited for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down RPG Life Sciences Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see RPGLIFE company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs1.32 Billion 18.68%
Short-term Investments Rs917.20 Million 13.0%
Total Liquid Assets Rs2.24 Billion 31.67%

Asset Resilience Insights

  • Very High Liquidity: RPG Life Sciences Limited maintains exceptional liquid asset reserves at 31.67% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

RPG Life Sciences Limited Industry Peers by Asset Resilience Ratio

Compare RPG Life Sciences Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for RPG Life Sciences Limited (2017–2025)

The table below shows the annual Asset Resilience Ratio data for RPG Life Sciences Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 39.81% Rs2.62 Billion
≈ $28.32 Million
Rs6.58 Billion
≈ $71.14 Million
+15.80pp
2024-03-31 24.01% Rs1.23 Billion
≈ $13.32 Million
Rs5.13 Billion
≈ $55.46 Million
-5.13pp
2023-03-31 29.14% Rs1.22 Billion
≈ $13.22 Million
Rs4.19 Billion
≈ $45.35 Million
+25.41pp
2022-03-31 3.73% Rs128.60 Million
≈ $1.39 Million
Rs3.45 Billion
≈ $37.27 Million
+3.23pp
2021-03-31 0.50% Rs15.30 Million
≈ $165.46K
Rs3.03 Billion
≈ $32.81 Million
+0.46pp
2020-03-31 0.04% Rs1.20 Million
≈ $12.98K
Rs2.67 Billion
≈ $28.85 Million
0.00pp
2019-03-31 0.05% Rs1.20 Million
≈ $12.98K
Rs2.51 Billion
≈ $27.17 Million
-0.24pp
2018-03-31 0.28% Rs8.30 Million
≈ $89.76K
Rs2.91 Billion
≈ $31.50 Million
+0.08pp
2017-03-31 0.20% Rs5.00 Million
≈ $54.07K
Rs2.46 Billion
≈ $26.63 Million
--
pp = percentage points

About RPG Life Sciences Limited

NSE:RPGLIFE India Drug Manufacturers - Specialty & Generic
Market Cap
$410.49 Million
Rs37.96 Billion INR
Market Cap Rank
#13558 Global
#642 in India
Share Price
Rs2295.00
Change (1 day)
+13.03%
52-Week Range
Rs1744.00 - Rs2657.80
All Time High
Rs2828.55
About

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more